News

Second vCJD patient to receive experimental treatment

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7420.886-a (Published 16 October 2003) Cite this as: BMJ 2003;327:886
  1. Clare Dyer, legal correspondent
  1. BMJ

    Doctors treating an 18 year old girl in the north of England with variant Creutzfeldt-Jakob disease (vCJD) were given the go-ahead last week to inject her brain with pentosan polysulphate, an experimental treatment tried earlier this year on a Belfast teenager with the disease.

    Dame Elizabeth Butler-Sloss, president of the High Court's family division, who gave the green light last December for 19 year old Jonathan Simms to have the treatment (BMJ 2003;326: 8), …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe